Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
China: Demand for GLP-1 receptor agonists in China is projected to rise at 7.1% CAGR through 2036
This step is also called a flow check or safety test
You are actively engaged in a weight management program (including diet and exercise) and want to support your body's fat metabolism
Are testimonials being used as clinical evidence
This will eventually include Medicare [as well as commercial players], where we see coverage by the end of the decade based on the expected strength of these datasets. As with diabetes, JPM also sees the obesity market to be a $50 billion one by 2030 and largely a duopoly between Lilly and Novo
US$ 25.54
US$ 28.47
US$ 23.18
